RIKEN:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:RIKEN - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9433
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
RIKEN is a research organization that carries out basic and applied science research programs. The organization’s research system consists of strategic research centers, research infrastructure centers, chief scientist system, etc. and a cluster for industry partnerships. Its centers, research spans in range of natural sciences, from developmental biology and neuroscience to quantum physics, computer science and green innovation. RIKEN enters into external collaboration and works in partnership with private companies to transform its scientific developments into commercial products. The organization operates through facilities in Wako, Tsukuba, Yokohama, Kobe and Harima. RIKEN is headquartered in Wako, Japan.

RIKEN – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
RIKEN, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RIKEN, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
RIKEN, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RIKEN, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
RIKEN, Medical Devices Deals, 2012 to YTD 2018 9
RIKEN, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
RIKEN, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Center for iPS Cell Research and Application, Takeda Pharma and RIKEN Enter into Partnership 11
Santen Pharma Enters into Research Agreement with Riken and Foundation for Biomedical Research and Innovation 12
RIKEN and Otsuka Pharma Forms Joint Venture 13
Ambicion Enters into Research Agreement with RIKEN 14
Shin Nippon Biomedical Labs Enters Into Research Agreement With Riken 15
Riken Enters Into Agreement With Takeda Pharma To Form Riken Bsi-Takeda Collaboration Center 16
Licensing Agreements 17
Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 17
Mitsubishi Chemical Medience Enters Into Licensing Agreement With Shimadzu And Riken 18
RIKEN – Key Competitors 19
RIKEN – Key Employees 20
RIKEN – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Government and Public Interest 23
Apr 18, 2018: Researchers uncover origin of virus-fighting plasma B cells 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
RIKEN, Pharmaceuticals & Healthcare, Key Facts 2
RIKEN, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RIKEN, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
RIKEN, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RIKEN, Deals By Therapy Area, 2012 to YTD 2018 8
RIKEN, Medical Devices Deals, 2012 to YTD 2018 9
RIKEN, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Center for iPS Cell Research and Application, Takeda Pharma and RIKEN Enter into Partnership 11
Santen Pharma Enters into Research Agreement with Riken and Foundation for Biomedical Research and Innovation 12
RIKEN and Otsuka Pharma Forms Joint Venture 13
Ambicion Enters into Research Agreement with RIKEN 14
Shin Nippon Biomedical Labs Enters Into Research Agreement With Riken 15
Riken Enters Into Agreement With Takeda Pharma To Form Riken Bsi-Takeda Collaboration Center 16
Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 17
Mitsubishi Chemical Medience Enters Into Licensing Agreement With Shimadzu And Riken 18
RIKEN, Key Competitors 19
RIKEN, Key Employees 20
RIKEN, Subsidiaries 21

List of Figures
RIKEN, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
RIKEN, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
RIKEN, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
RIKEN, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
RIKEN, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RIKEN, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
RIKEN, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RIKEN, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
RIKEN, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[RIKEN:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sinochem International Corp (600500):企業の財務・戦略的SWOT分析
    Sinochem International Corp (600500) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • 3D Systems Corp (DDD):企業の財務・戦略的SWOT分析
    3D Systems Corp (DDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hydra Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Hydra Biosciences Inc (Hydra) is a biopharmaceutical company that develops novel drugs to treat pain, inflammation, anxiety and other diseases. The company’s pipeline candidate HX-100 is developed to treat diabetic neuropathy and allergic asthma. It offers other drugs for the therapeutic are …
  • Yakult Honsha Co Ltd (2267):製薬・医療:M&Aディール及び事業提携情報
    Summary Yakult Honsha Co Ltd (Yakult) is a probiotics company that undertakes the development, manufacture and commercialization of probiotic and pharmaceutical products. The company’s product portfolio encompasses food and beverages such as fermented milk drinks, juice and others products; pharmace …
  • Sumitomo Corp (8053):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Corp (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resources and …
  • Greenergy International Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Greenergy International Ltd (GIL) is an energy company that sells petroleum products. The company’s products include petrol, diesel, biodiesel, ultra-low sulphur gasoil, bioethanol, kerosene and ULSG. It offers manufacturing and infrastructure, fuel supply, infrastructure investment, biofuel …
  • Rocky Mountain Chocolate Factory, Inc.:企業の戦略・SWOT・財務情報
    Rocky Mountain Chocolate Factory, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rocky Mountain Chocolate Factory, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Oranje-Nassau Energie BV:石油・ガス:M&Aディール及び事業提携情報
    Summary Oranje-Nassau Energie BV (ONE) is an upstream oil and gas company which focuses on the exploration and production of oil and natural gas. It concentrates on exploration assets in the southern North Sea Ventures such as the Netherlands and the UK. It also has assets in Kowe Block and Agali Bl …
  • Protalix BioTherapeutics Inc (PLX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protalix BioTherapeutics Inc (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company’s marketed product, Taliglucerase (taliglucerase alfa) is an enzyme replacement therapy (ERT) for the long-term treatment of adult patients wi …
  • Exide Technologies:企業の戦略的SWOT分析
    Exide Technologies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • PTT Public Company Limited:企業の戦略・SWOT・財務分析
    PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Federal Home Loan Mortgage Corporation:企業の戦略・SWOT・財務情報
    Federal Home Loan Mortgage Corporation - Strategy, SWOT and Corporate Finance Report Summary Federal Home Loan Mortgage Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Yapi Merkezi Holding Inc.
    Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report Summary Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Falck Renewables S.p.A. (FKR)-エネルギー分野:企業M&A・提携分析
    Summary Falck Renewables S.p.A. (Falck Renewables), formerly Actelios S.p.A., develops, designs, constructs and manages energy production plants. It operates as a subsidiary of Falck S.p.A. The company produces clean energy from various renewable sources including wind energy, solar energy, biomass …
  • Brembo SpA:企業の戦略・SWOT・財務情報
    Brembo SpA - Strategy, SWOT and Corporate Finance Report Summary Brembo SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bank of Japan (8301):企業の財務・戦略的SWOT分析
    Bank of Japan (8301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Enel Green Power SpA:企業の戦略的SWOT分析
    Enel Green Power SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • China State Construction International Holdings Limited:戦略・SWOT・企業財務分析
    China State Construction International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary China State Construction International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • American Tower Corp (AMT):企業の財務・戦略的SWOT分析
    American Tower Corp (AMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gildan Activewear Inc (GIL):企業の財務・戦略的SWOT分析
    Gildan Activewear Inc (GIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆